Open Actively Recruiting

(MTPA) OXIDATIVE MARKERS AND EFFICACY IN ALS/MND PHENOTYPES TREATED WITH EDARAVONE

About

Brief Summary

This study has not yet been registered on ClinicalTrials.gov, which is currently a pre-requisite for display of detailed eligibility criteria.

Join this Trial

Contact our clinical trial navigators for opportunities that may be suitable for you
Share:
Study Stats
Protocol No.
20-001171
Category
Brain/Neurological Diseases
Principal Investigator
MARTINA WIEDAU-PAZOS
Location
  • UCLA Westwood